SCHEMBL20340950

SCHEMBL20340950

CCN(CCF)C(=O)OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR6 P51684 1/20 0.50
PAX8 Q06710 1/20 0.50
ALDH1A1 P00352 6/20 0.49
PTGDR2 Q9Y5Y4 3/20 0.46
LMNA P02545 1/20 0.45
MAPK1 P28482 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 1/20 0.43
TBXA2R P21731 1/20 0.43
PTGIR P43119 1/20 0.43
PTGDR Q13258 1/20 0.43
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
NPC1 O15118 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1328808 0.88 CCR6 (0.50) CCR6PAX8ALDH1A1PTGDR2LMNA
SCHEMBL18594775 0.88 CCR6 (0.52) CCR6PAX8ALDH1A1PTGDR2LMNA
SCHEMBL16665613 0.87 ALDH1A1 (0.58) CCR6PAX8ALDH1A1PTGDR2LMNA
SCHEMBL554131 0.86 CCR6 (0.55) CCR6PAX8ALDH1A1PTGDR2LMNA
SCHEMBL7366351 0.85 CCR6 (0.53) CCR6PAX8ALDH1A1PTGDR2LMNA
SCHEMBL9942494 0.85 CCR6 (0.57) CCR6PAX8ALDH1A1PTGDR2LMNA
SCHEMBL5058969 0.84 CCR6 (0.50) CCR6PAX8ALDH1A1PTGDR2LMNA
SCHEMBL13687190 0.83 LMNA (0.62) CCR6PAX8ALDH1A1PTGDR2LMNA
SCHEMBL11425197 0.82 CCR6 (0.54) CCR6PAX8ALDH1A1PTGDR2LMNA
SCHEMBL17846650 0.82 CCR6 (0.54) CCR6PAX8ALDH1A1PTGDR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10010549-B2 Biheteroaryl compounds and uses thereof GENENTECH, INC. (US) 2018-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10010549-B2 Biheteroaryl compounds and uses thereof BCHE, SNCA, HAX1 CCR6 1856/4885PAX8 2103/4885ALDH1A1 950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.